Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Argus Health
US Army
Cerilliant
Cipla
Express Scripts
Julphar
Federal Trade Commission

Generated: June 21, 2018

DrugPatentWatch Database Preview

Claims for Patent: 8,263,054

« Back to Dashboard

Summary for Patent: 8,263,054
Title:Method of enhancing hair growth
Abstract: Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I ##STR00001## wherein the dashed bonds represent a single or double bond which can be in the cis or trans configuration, A, B, Z, X, R.sub.1 and R.sub.2 are as defined in the specification. Such compositions are used in treating the skin or scalp of a human or non-human animal. Bimatoprost is preferred for this treatment.
Inventor(s): Woodward; David F. (Lake Forest, CA), Vandenburgh; Amanda M (Huntington Beach, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:13/356,284
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,263,054
Patent Claims: 1. A method of increasing eyelash growth in a human including length, thickness and darkness of the eyelashes, the method comprising administering bimatoprost to an eyelid margin of the human.

2. The method of claim 1 wherein the bimatoprost is administered in the form of a liquid composition containing about 0.03% w/v bimatoprost.

3. The method of claim 1 wherein bimatoprost is administered to the upper eyelid margin at least once a day.

4. The method of claim 1 wherein the bimatoprost is applied by direct contact with the upper eyelid margin.

5. The method of claim 1 wherein the patient is suffering from eyelash loss.

6. A method of increasing one or more of length, thickness and number of eyelashes in a human, comprising administering a composition comprising bimatoprost to the upper eyelid margin at least once a day.

7. The method of claim 6 wherein the bimatoprost is administered in the form of a liquid composition containing about 0.001% w/v to about 0.1% w/v of bimatoprost.

8. The method of claim 6 wherein the bimatoprost comprises about 0.03% w/v of the composition.

9. The method of claim 6 wherein the bimatoprost comprises 0.03% w/v of the composition.

10. The method of claim 6 wherein the bimatoprost is applied to the upper eyelid margin once a day.

11. The method of claim 6 wherein the human is suffering from eyelash loss.

12. The method of claim 6 wherein the human is suffering from alopecia.

13. A method of increasing eyelash growth in a human, the method comprising administering bimatoprost to an eyelid margin of the human.

14. The method of claim 13 wherein the bimatoprost is administered in the form of a liquid composition containing about 0.03% w/v bimatoprost.

15. The method of claim 14 wherein bimatoprost is administered to the upper eyelid margin at least once a day.

16. The method of claim 13 wherein the bimatoprost is applied by direct contact with the eyelid margin.

17. The method of claim 13 wherein the bimatoprost is in the form of a liquid composition containing 0.03% w/v bimatoprost.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Chubb
Dow
Covington
Boehringer Ingelheim
Chinese Patent Office
Farmers Insurance
Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.